Physostigmine for dementia due to Alzheimer's disease-Reference-Cited by-同舟云学术

Physostigmine for dementia due to Alzheimer's disease

Published:2001-04-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Coelho Filho João M JMC¹,Birks Jacqueline²

Affiliation:

1. Universidade Federal do Ceara; Departamento de Medicina Clinica; Rua Eduardo Garcia 650, Apto. 1400 Fortaleza Ceara Brazil 60.150.100

2. University of Oxford; Centre for Statistics in Medicine; Wolfson College Linton Road Oxford UK OX2 6UD

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD001499/fullpdf

Reference73 articles.

1. Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease;Asthana;Clinical Pharmacology and Therapeutics,1995

2. Asthana S Greig NH Raffaele KC Berardi A Schapiro MB Soncrant TT Pharmacokinetic and pharmacodynamic properties of physostigmine following steady-state intravenous infusion in subjects with Alzheimer's disease Proceedings of the Annual Scientific Meeting of the American Geriatrics Society and the American Federation for Aging Research, May 19-22 Los Angeles CA 1994

3. Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine;Asthana;Alzheimer Disease and Associated Disorders,1995

4. Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease;Asthana;Alzheimer Disease and Associated Disorders,1999

5. Efficacy of oral physostigmine in primary degenerative dementia: a double blind study of response to different dose level;Beller;Psychopharmacology,1985

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroretentive Delivery Approach to Address pH-Dependent Degradation of (+)- and (-)-Phenserine;AAPS PharmSciTech;2024-08-27

2. Synthesis and characterization of novel indole-cyanoacetic acid derivative and its applications;Journal of Solid State Electrochemistry;2024-08-19

3. Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights;Brain Research;2024-07

4. Carbamate as a potential anti‐Alzheimer's pharmacophore: A review;Drug Development Research;2023-09-11

5. Characterization, optimization, and in vitro evaluation of cholesterol-free liposomes;Journal of Drug Delivery Science and Technology;2023-06